Influenza virus cell entry and targeted antiviral development

Area of Science:

• Virology
• Infectious Diseases
• Drug Discovery

Background:

• Influenza virus is a highly transmissible global pathogen causing annual outbreaks and pandemics.
• Existing antiviral drugs face challenges like resistance, necessitating novel therapeutic strategies.
• Inhibiting influenza virus entry into host cells is a promising research avenue.

Purpose of the Study:

• To review recent advancements in natural products and small molecules as potential anti-influenza agents.
• To discuss proteins, peptides, and antibody-like proteins targeting viral entry.
• To highlight the biological significance of hemagglutinin in influenza virus replication.

Main Methods:

• Literature review of natural products with anti-influenza activity.
• Analysis of small molecules inhibiting viral entry.
• Examination of protein, peptide, and antibody-based therapeutics.
• Discussion of hemagglutinin's role in viral replication.

Main Results:

• Various natural products, small molecules, proteins, and peptides demonstrate anti-influenza activity.
• Inhibitors of hemagglutinin-mediated viral entry are key targets.
• Neutralizing antibody-like proteins show therapeutic potential.

Conclusions:

• Targeting influenza virus entry presents a vital strategy for developing new antiviral drugs.
• A diverse range of compounds, including natural products and biologics, show promise.
• Further research is needed to develop effective therapies against influenza.